<<
>>

.. : ....- . . -, 2006.

..

//. . . 1996. 1. . 14

.. , , . ... ... 14.00.25 - , , 2009, 23.

.., .., .., .. -- . 2367427,2008.

Acheson A, Conover JC, Fandl JP, DeChiara TM, Russell M, Thadani A, Squinto SP, Yancopoulos GD, Lindsay RM. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature. 1995;374(6521):450-453.

Allagui MS, Nciri R, Rouhaud MF, Murat JC, El Feki A, Croute F, Vincent

C. Long-term exposure to low lithium concentrations stimulates proliferation, modifies stress protein expression pattern and enhances resistance to oxidative stress in SH-SY5Y cells. Neurochem Res. 2009;34(3):453-62 Epub 2008 Au.

Almeida M, Han L, Bellido T, Manolagas SC, Kousteni S. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem. 2005;280(50):41342-51 Epub 2005.

Angelucci F, Aloe L, Jimenez-Vasquez P, Mathe AA. Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression. Int J Neuropsychopharmacol 2003;6(3):225-231.

Axelrod J. Phospholipase A2 and G proteins. Trends Neurosci. 1995;18(2):64-65.

Bading H., Ginty D. D., Greenberg M. E., 1993, Science 260:181-186.

Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A, Izquierdo I, Medina JH. BDNF is essential to promote persistence of long-term memory storage. Proc Natl Acad Sci U S A. 2008;105(7):2711-6 Epub 2008 Fe.

Boissier J, Simon P, Lwoff J. Use of a particular mouse reaction ( hole board method) for the study of psychotropic drugs. Therapie. 1964 May-Jun; 19:571 -83

Bosetti F, Rintala J, Seemann R, Rosenberger TA, Contreras MA, Rapoport SI, Chang MC. Chronic lithium downregulates cyclooxygenase- 2 activity and prostaglandin E(2) concentration in rat brain. Mol Psychiatry. 2002;7(8):845-850.

Bramham CR, et al. Unilateral LTP triggers bilateral increases in hippocampal neurotrophin and trk receptor mRNA expression in behaving rats: evidence for interhemispheric communication. J Camp Neurol. 1996;368:371-382.

Bush AL, Hyson RL. Lithium increases bcl-2 expression in chick cochlear nucleus and protects against deafferentation-induced cell death.

Neuroscience. 2006;138(4):1341-9 Epub 2006 Ja.

Castrtin E, et al. Light regulates expression of brain-derived neurotrophic factor mRNA in rat visual cortex. Proc Natl Acad Sci USA. 1992;89:9444-9448.

Castrtin E, et al. The induction of LTP increases BDNF and NGF mRNA but decreases NT-3 mRNA in the dentate gyrus. Neuroreport. 1993;4:895-898.

Castrtin E, Thoenen H, Lindholm D. Brain-derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult rat brain and is increased by osmotic stimulation in the paraventricular nucleus. Neuroscience. 1995;64:71-80. Castrtin E, et al. Regulation of brain-derived neurotrophic factor mRNA levels in hippocampus by neuronal activity. Prog Brain Res. 1998;117:57-64.

Chalecka-Franaszek E, Chuang DM. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci U S A. 1999;96(15):8745-8750.

Chang MC, Jones CR. Chronic lithium treatment decreases brain phospholipase A2 activity. Neurochem Res. 1998;23(6):887-892.

Chiu CT, Chuang DM. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther. 2010;128(2):281 -304 Epub 2010 A.

Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl). 2001;158(1):100-106.

Gogolla N, Galimberti I, Deguchi Y, Caroni P. Wnt signaling mediates experience-related regulation of synapse numbers and mossy fiber connectivities in the adult hippocampus. Neuron. 2009;62(4):510-525.

Gold AB, Herrmann N, Lanctot KL. Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelae. Curr Drug Targets. 2011;12(2):243-255.

Cotman CW, Berchtold NC.Exercise: a behavioral intervention to enhance brain health andplasticity.Trends Neurosci. 2002 Jun;25(6):295-301.

Guo S, Arai K, Stins MF, Chuang DM, Lo EH. Lithium upregulates vascular endothelial growth factor in brain endothelial cells and astrocytes. Stroke. 2009;40(2):652-5 Epub 2008 Oct.

Hall C.S. The method of open field// J.Comparative Psychology.-1934.- N18.-P.385-403.

Hallcher LM, Sherman WR. The effects of lithium ion and other agents on the activity of myo-inositol-1 -phosphatase from bovine brain. J Biol Chem. 198 0;255(22):10896-10901.

Hashimoto R, Fujimaki K, Jeong MR, Senatorov VV, Christ L, Leeds P, Chuang DM, Takeda M. Neuroprotective actions of lithium. Seishin Shinkeigaku Zasshi. 2003;105(1):81 -86.

Hashimoto R, Takei N, Shimazu K, Christ L, Lu B, Chuang DM. Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity. Neuropharmacology. 2002;43(7):1173-1179.

Hellweg R, Lang UE, Nagel M, Baumgartner A. Subchronic treatment with lithium increases nerve growth factor content in distinct brain regions of adult rats. Mol Psychiatry. 2002;7(6):604-608.

Hollander E, Buchsbaum MS, Haznedar MM, Berenguer J, Berlin HA, Chaplin W, Goodman CR, LiCalzi EM, Newmark R, Pallanti S.FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. Neuropsychobiology. 2008;58(1):37-47.

Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu RevNeurosci. 2001;24:677-736.

Jean YY, Lercher LD, Dreyfus CF. Glutamate elicits release of BDNF from basal forebrain astrocytes in a process dependent on metabotropic receptors and the PLC pathway. Neuron Glia Biol. 2008;4(1):35-42.

Johnson C. M., Hill C. S., Chawla S., Treisman R., Bading H., 1997, J. Neurosci. 17:6189-6202.

Keeble TR, Halford MM, Seaman C, Kee N, Macheda M, Anderson RB, Stacker SA, Cooper HM. The Wnt receptor Ryk is required for Wnt5a-mediat- ed axon guidance on the contralateral side of the corpus callosum. J Neurosci. 2006;26(21):5840-5848.

Kolarow R, Brigadski T, Lessmann V. Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium calmodulin kinase II signaling and proceeds via delayed fusion pore opening. J Neurosci. 2007;27(39):10350-10364.

Kolarow R, Brigadski T, Lessmann V. Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium calmodulin kinase II signaling and proceeds via delayed fusion pore opening. J Neurosci. 2007 Sep 26;27(39):10350-64.

Leyhe T, Eschweiler GW, Stransky E, Gasser T, Annas P, Basun H, Laske C. Increase of BDNF serum concentration in lithium treated patients with early Alzheimers disease. J Alzheimers Dis. 2009;16(3):649-656.

Liang H, Coles AH, Zhu Z, Zayas J, Jurecic R, Kang J, Jones SN. Noncanonical Wnt signaling promotes apoptosis in thymocyte development. J Exp Med. 2007;204(13):3077-84 Epub 2007 D.

Lindholm D, Castren E, Berzaghi M, Blochl A, Thoenen H. Activity-dependent and hormonal regulation of neurotrophin mRNA levels in the brain-implications for neuronal plasticity. J Neurobiol. 1994;25(11):1362-1372.

Liu F, Gong X, Zhang G, Marquis K, Reinhart P, Andree TH. The inhibition ofglyco- gen synthase kinase 3beta by a metabotropic glutamate receptor5 mediated pathway confers neuroprotection toAbeta peptides. J Neurochem. 2005;95(5): 1363-72.

Luo J. Lithium-mediated protection against ethanol neurotoxicity. Front Neurosci. 2010;4:41.

Lyoo IK, Dager SR, Kim JE, Yoon SJ, Friedman SD, Dunner DL, Renshaw PF. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Neurop- sychopharmacol 2010;35(8):1743-50 Epub 2010 M.

Machado-Vieira R, Manji HK, Zarate CA Jr. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord. 2009;11 Suppl 2:92-109.

Marx CE, Yuan P, Kilts JD, Madison RD, Shampine LJ, Manji HK. Neuroactive steroids, mood stabilizers, and neuroplasticity: alterations following lithium and changes in Bcl-2 knockout mice. Int J Neuropsychopharmacol2008; 11(4):547-52.

McGovern A, Carreno F, Cunningham J. Fyn kinase-TrkB receptor- NMDAR2B glutamate receptor subunit (NR2B) physical interaction is increased in the supraoptic nuclei (SON) following dehydration in the rat. FASEB J. April 2010 24 (Meeting Abstract Supplement) 1025.17

Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK. Lithium-induced increase in human brain grey matter. Lancet. 2000;356(9237):1241-1242.

Omata N, Murata T, Takamatsu S, Maruoka N, Mitsuya H, Yonekura Y, Fu- jibayashi Y, Wada Y. Neuroprotective effect of chronic lithium treatment against hypoxia in specific brain regions with upregulation of cAMP response element binding protein and brain-derived neurotrophic factor but not nerve growth factor: comparison with acute lithium treat Bipolar Disord. 2008;10(3):360-368.

Patterson SL, et al. Neurotrophin expression in rat hippocampal slices: a stimulus paradigm inducing LTP in CA1 evokes increases in BDNF and NT-3 mRNAs. Neuron. 1992;9:1081-1088.

Patterson SL, et al. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron. 1996;16:1137-1145.

Plant KE, Anderson E, SimecekN, Brown R, Forster S, Spinks J, Toms N, Gibson GG, Lyon J, Plant N. The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009;235(1):124-34

Purves, Dale; George J. Augustine, David Fitzpatrick, William C. Hall, Anthony-Samuel LaMantia, James O. McNamara, Leonard E. White (2008). Neuroscience, 4th Ed.. Sinauer Associates. pp. 191-195. ISBN 978-0-87893-697-7.

Rantamaki T, Knuuttila JE, Hokkanen ME, Castren E. The effects of acute and long-term lithium treatments on trkB neurotrophin receptor activation in the mouse hippocampus and anterior cingulate cortex. Neuropharmacology. 2006;50(4):421-7.

Rhoads AR, Karkera JD, Detera-Wadleigh SD. Radiation hybrid mapping of genes in the lithium-sensitive wnt signaling pathway. Mol Psychiatry. 1999;4(5):437-442.

RintalaJ, SeemannR, ChandrasekaranK, RosenbergerTA, ChangL, Contreras MA, Contreras MA, Rapoport SI, Chang MC. 85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain. Neuroreport. 1999;10( 18):3887-3890.

Rocamora N, et al. Upregulation of BDNF mRNA expression in the barrel cortex of adult mice after sensory stimulation. J Neurosci. 1996;16:4411-4419.

Sano K., Nanba H., TabuchiA., Tsuchiya T., Tsuda M., 1996, Biochem. Bio- phys. Res. Commun. 229:788-793.

Sasaki T, Han F, Shioda N, Moriguchi S, Kasahara J, Ishiguro K, Fuku- naga K. Lithium-induced activation of Akt and CaM kinase II contributes to its neuroprotective action in a rat microsphere embolism model. Brain Res. 2006;1108(1):98-106.

Sassi rB, Nicoletti M, Brambilla P, Mallinger AG, Frank E, Kupfer DJ, Kes- havan MS, Soares JC. Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci Lett. 2002;329(2):243-245.

Sharifzadeh M, Aghsami M, Gholizadeh S, Tabrizian K, Soodi M, Khalaj S, Ranjbar A, Hosseini-Sharifabad A, RoghaniA, Karimfar MH. Protective effects of chronic lithium treatment against spatial memory retention deficits induced by the protein kinase AII inhibitor H-89 in rats. Pharmacology. 2007;80(2-3):158-65

Su H, Zhang W, Guo J, Guo A, Yuan Q, Wu W. Lithium enhances the neuronal differentiation of neural progenitor cells in vitro and after transplantation into the avulsed ventral horn of adult rats through the secretion of brain-derived neurotrophic factor. J Neurochem. 2009;108(6):1385-98

Tabuchi A, Nakaoka R, Amano K, Yukimine M, Andoh T, Kuraishi Y, Tsuda M. Differential activation of brain-derived neurotrophic factor gene promoters I and III by Ca2+ signals evoked via L-type voltage-dependent and N-methyl-D- aspartate receptor Ca2+ channels. J Biol Chem. 2000;275(23):17269-17275.

Tajes M, Yeste-Velasco M, Zhu X, Chou SP, Smith MA, Pallas M, Camins A, Casadesus G. Activation of Akt by lithium: pro-survival pathways in aging. Mech Ageing Dev. 2009;130(4):253-61

Wang H, Huang W, Sugawara M, Devoe LD, Leibach FH, Prasad PD, Ga- napathy V. Cloning and functional expression of ATA1, a subtype of amino acid transporter A, from human placenta. Biochem Biophys Res Commun. 2000;273(3):1175-1179.

Wang JM, Singh C, Liu L, Irwin RW, Chen S, Chung EJ, Thompson RF, Brinton RD. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimers disease. Proc Natl Acad Sci U S A. 2010;107(14):6498-503

Xia Z., Dudek H., Miranti C. K., Greenberg M. E., 1996, J. Neurosci. 16:5425-5436.

Xu J, Culman J, Blume A, Brecht S, Gohlke P. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death. Stroke. 2003;34(5):1287-92 Epub 2003 A.

Yamada K, Nabeshima T. Brain-derived neurotrophic factor/TrkB signaling in memory processes. J Pharmacol Sci. 2003;91(4):267-270.

Young W. Review of lithium effects on brain and blood. Cell Transplant. 2009;18(9):951-75

Yun SI, Yoon HY, Chung YS. Glycogen synthase kinase-3beta regulates etoposide-induced apoptosis via Bcl-2 mediated caspase-3 activation in C3H10T1/2 cells. Apoptosis. 2009;14(6):771-777.

Zafra F., Zhengerer B., Leibrock J., Thoenen H., Lindholm D., 1990, EMBO

J. 9:3545-3550.

<< | >>
: . ., . .. - 61 . - .: , 2012- 747 .. 2012

:

- -
- - - - - - - - - - - - - -